Optimind Pharma Corp. (CSE:OMND)

Optimind Pharma Statistics

Total Valuation

Optimind Pharma has a market cap or net worth of CAD 548,942. The enterprise value is 572,002.

Market Cap	548,942
Enterprise Value	572,002

Important Dates

The next estimated earnings date is Friday, June 27, 2025.

Earnings Date	Jun 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Optimind Pharma has 109.79 million shares outstanding. The number of shares has increased by 12.33% in one year.

Current Share Class	n/a
Shares Outstanding	109.79M
Shares Change (YoY)	+12.33%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	3.13%
Owned by Institutions (%)	n/a
Float	106.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.94
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.64
EV / Sales	5.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.62

Current Ratio	0.62
Quick Ratio	0.62
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.44

Financial Efficiency

Return on equity (ROE) is -2,694.02% and return on invested capital (ROIC) is -51.60%.

Return on Equity (ROE)	-2,694.02%
Return on Assets (ROA)	-38.87%
Return on Invested Capital (ROIC)	-51.60%
Return on Capital Employed (ROCE)	654.72%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.04
52-Week Price Change	n/a
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	44.47
Average Volume (20 Days)	106

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Optimind Pharma had revenue of CAD 111,328 and -895,115 in losses. Loss per share was -0.01.

Revenue	111,328
Gross Profit	72,616
Operating Income	-315,085
Pretax Income	-903,874
Net Income	-895,115
EBITDA	n/a
EBIT	-315,085
Loss Per Share	-0.01

Balance Sheet

The company has 102,579 in cash and 125,637 in debt, giving a net cash position of -23,058 or -0.00 per share.

Cash & Cash Equivalents	102,579
Total Debt	125,637
Net Cash	-23,058
Net Cash Per Share	-0.00
Equity (Book Value)	-48,125
Book Value Per Share	-0.00
Working Capital	-98,125

Cash Flow

Operating Cash Flow	-199,292
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	65.23%
Operating Margin	-283.02%
Pretax Margin	-811.90%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	-283.02%
FCF Margin	n/a

Dividends & Yields

Optimind Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.33%
Shareholder Yield	-12.33%
Earnings Yield	-163.06%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Optimind Pharma has an Altman Z-Score of -36.37. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-36.37
Piotroski F-Score	n/a